Global Human Augmentation Strategic Business Report 2023: Wearable AI Exudes Immense Potential to Augment Human Intelligence
April 14, 2023 11:03 ET
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Human Augmentation: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Human...
Global Human Augmentation Market Report 2022-2026 - Human Augmentation Technologies Sense Robust Opportunities in Industrial Sector
June 28, 2022 05:33 ET
|
Research and Markets
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Human Augmentation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Human Augmentation...
NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD
June 14, 2022 11:00 ET
|
NeuroSigma, Inc.
Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...
PetVivo Holdings, Inc. exhibits at American Association of Equine Practitioners Conference in Nashville, TN
December 13, 2021 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Dec. 13, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical...
PETVIVO HOLDINGS, INC. NAMES KICK (“IDEAS THAT KICK”) AS ITS AGENCY FOR BRANDING AND ADVERTISING
October 27, 2021 10:27 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Oct. 27, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics...
PetVivo Holdings, Inc. Engages Dr. Joe Manning as a Senior Technical Veterinarian
October 05, 2021 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Oct. 05, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Holdings Announces Closing of Public Offering and Nasdaq Listing
August 13, 2021 14:47 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Aug. 13, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (“PetVivo” or the “Company”), an emerging biomedical device company focused on the licensing and...
PetVivo Holdings Announces Pricing of Public Offering and Nasdaq Listing
August 10, 2021 20:32 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Aug. 10, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (“PetVivo” or the “Company”), an emerging biomedical device company focused on the licensing and...
PetVivo Holdings, Inc. Announces Sponsored Research Agreement with Colorado State University for Osteoarthritis Treatment Study.
November 12, 2020 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- OTCQB: (PETV) PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the commercialization of innovative medical...
PETVIVO HOLDINGS, INC. HIRES DR. DAVID B MASTERS AS DIRECTOR OF SCIENCE AND TECHNOLOGY
September 10, 2020 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Sept. 10, 2020 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for...